Humoral Acute Rejection in a Kidney Transplant Recipient with Idiopathic Thrombocytopenic Purpura
Author(s) -
Ana Paola Rico-Portillo,
José Ignacio CerrillosGutiérrez,
Jorge AndradeSierra,
Alfredo GutiérrezGovea,
Enrique Rojas–Campos,
Claudia Alejandra Mendoza-Cerpa,
Benjamín Gómez-Navarro
Publication year - 2021
Publication title -
case reports in transplantation
Language(s) - English
Resource type - Journals
eISSN - 2090-6943
pISSN - 2090-6951
DOI - 10.1155/2021/9933354
Subject(s) - medicine , plasmapheresis , rituximab , thrombotic microangiopathy , splenectomy , abo blood group system , adamts13 , antibody , gastroenterology , renal function , platelet , thrombotic thrombocytopenic purpura , immunology , thrombocytopenic purpura , microangiopathy , disease , spleen , diabetes mellitus , endocrinology
A 47-year-old male was diagnosed with chronic kidney disease (CKD) in 2011; idiopathic thrombocytopenic purpura (ITP) was also diagnosed in 2011 refractory to medical treatment and finally treated with splenectomy (2017) without relapses since that date, 5 blood transfusions, and 4 platelet apheresis in 2017. Renal transplant from a living related donor (brother), ABO compatible, crossmatch were negative, sharing 1 haplotype. Donor-specific anti-HLA antibody was negative. Graft function was stable until the 5 th day and graft biopsy on the 6 th day; thrombotic microangiopathy (TMA), C4D negative and inflammatory infiltration of polymorphonuclear leukocytes inside peritubular capillary, and anti-MICA antibodies were positive. The treatment used were plasmapheresis, intravenous immunoglobulin, and rituximab. Serum creatinine began to decrease since the 14 th day, and by day 33, post-RT graft function was restored.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom